FluQuadri Inactivated Quadrivalent Influenza Vaccine (Split Virion), Influenza virus haemagglutinin 60 mcg, 0.5 mL suspension for injection, Sanofi Aventis Australia Pty Ltd, CON-274

1. The test for Bacterial Endotoxins (2.6.14) and the assay of Haemagglutinin Antigen by an immunodiffusion test (2.7.1), are performed on the Final Bulk Product only and not performed on the Final Filled product. 2. The batch is packaged in the Standard Export labelling (in Spanish and English), which does not conform with the requirements of the TGO 91 on the following#58;' Paragraph 8(1)(d) the name of the dosage form (missing on carton)' Paragraph 8(1)(i) the name and contact details of the sponsor (missing on carton)' Paragraph 8(1)(j)(iv)(A) indicating that the medicine contains the substance expressed using the Name stated in Column 4 of Schedule 1 (statement regarding manufactured in eggs missing on carton)' Paragraph 9(1)(b) the name(s) of all active ingredients in the medicine (missing on syringe)' Paragraph 9(1)(c) the quantity or proportion of all active ingredients in the medicine (missing on syringe)'Subsection 9(3) the name of the medicine and the name of active ingredients on the main label (they are placed separately as the same texts in Spanish are placed before English texts)' Paragraph 10(5)(c) the name of the medicine is displayed in a text size of not less than 1.5 millimetres (the trade name 'FluQuadri' is less than 1.5 mm on syringe)' Paragraph 11(1)(a) use of appropriate metric units (the abbreviation 'mcg' is used rather than 'microgram' in full on carton)' Subsection 11(5) permitted statements of storage temperature conditions ('Store between + 2ÌŠ C t o +8ÌŠ C . Do not freeze' is used rather than 'Store at 2oC t o 8oC' (Refrigerate. Do not freeze) on carton).